Cargando…
Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev(®)) in South Korea, 2015–2019
INTRODUCTION: The live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV; Imojev(®)) has been approved in South Korea for use in subjects aged ≥ 12 months since 2015. As part of the license agreement, a post-marketing surveillance study was undertaken to actively monitor the safety prof...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452989/ https://www.ncbi.nlm.nih.gov/pubmed/32474892 http://dx.doi.org/10.1007/s40121-020-00305-6 |